2020-11-12T09:47:39Z
2020-11-12T09:47:39Z
2019-04-01
2020-11-12T09:47:39Z
Poly(propylene imine) dendrimers have been shown to be promising 3-dimensional polymers for the use in the pharmaceutical andbiomedical applications. Our aims of this study were first, to synthesize a novel type of dendrimer with poly(propylene imine) core andmaltose-histidine shell (G4HisMal) assessing if maltose-histidine shell can improve the biocompatibility and the ability to cross the blood-brain barrier, and second, to investigate the potential of G4HisMal to protect Alzheimer disease transgenic mice from memory impairment.Our data demonstrate that G4HisMal has significantly improved biocompatibility and ability to cross the blood-brain barrier in vivo.Therefore, we suggest that a maltose-histidine shell can be used to improve biocompatibility and ability to cross the blood-brain barrier ofdendrimers. Moreover, G4HisMal demonstrated properties for synapse and memory protection when administered to Alzheimer diseasetransgenic mice. Therefore, G4HisMal can be considered as a promising drug candidate to prevent Alzheimer disease via synapse protection1
Article
Versió publicada
Anglès
Trastorns de la memòria; Neurologia; Polipropilè; Memory disorders; Neurology; Polypropylene
Future Medicine
Reproducció del document publicat a: https://doi.org/10.1016/j.nano.2019.01.010
Nanomedicine, 2019, vol. 17, p. 198-209
https://doi.org/10.1016/j.nano.2019.01.010
CC-BY (c) Future Medicine, 2019
http://creativecommons.org/licenses/by-cc-by/3.0/